Cargando…

Stakeholder involvement in the development of trial material for a clinical trial

BACKGROUND: Stakeholder involvement includes not just patients and public, but also those delivering treatment for example clinicians and students. Each stakeholder brings unique experiences to the process. The aim of this stakeholder exercise was to explore readability and understanding of the tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Rix, Jacqueline, Branney, Jonathan, Breen, Alexander C., Sewell, Philip, Docherty, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077147/
https://www.ncbi.nlm.nih.gov/pubmed/33316128
http://dx.doi.org/10.1111/hex.13181
_version_ 1783684827776548864
author Rix, Jacqueline
Branney, Jonathan
Breen, Alexander C.
Sewell, Philip
Docherty, Sharon
author_facet Rix, Jacqueline
Branney, Jonathan
Breen, Alexander C.
Sewell, Philip
Docherty, Sharon
author_sort Rix, Jacqueline
collection PubMed
description BACKGROUND: Stakeholder involvement includes not just patients and public, but also those delivering treatment for example clinicians and students. Each stakeholder brings unique experiences to the process. The aim of this stakeholder exercise was to explore readability and understanding of the trial material for the future trial to be conducted by the authors: Biomechanical Effects of Manual Therapy—A Feasibility Study. DESIGN: Volunteers from identified stakeholder groups were provided with trial material which included the information sheet, consent form, questionnaires and home management booklet. They provided feedback on content (readability, understanding) and style (font, layout). An additional document was provided with genres of pictures to choose the most appropriate style to be used in the booklet. Readability formulas were used to calculate reading age before and after feedback to objectively measure ease of reading. RESULTS: The public group provided a layperson's perspective to clarify the information sheet for patients, whereas practitioner and intern groups indicated where information could be clarified. The reading age of all documentation decreased following feedback; however, templated sections of the documentation did not. The majority (87%) of volunteers chose coloured classic cartoons for the booklet. CONCLUSION: This process highlighted the importance of involving different stakeholder groups in the development of research materials as each group made a unique contribution. Readability and understanding of the trial material were improved, feeding back into the consent process contributing towards fully informed consent. PATIENT OR PUBLIC CONTRIBUTION: Public helped develop materials for a future trial but not with manuscript preparation.
format Online
Article
Text
id pubmed-8077147
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80771472021-04-29 Stakeholder involvement in the development of trial material for a clinical trial Rix, Jacqueline Branney, Jonathan Breen, Alexander C. Sewell, Philip Docherty, Sharon Health Expect Original Research Papers BACKGROUND: Stakeholder involvement includes not just patients and public, but also those delivering treatment for example clinicians and students. Each stakeholder brings unique experiences to the process. The aim of this stakeholder exercise was to explore readability and understanding of the trial material for the future trial to be conducted by the authors: Biomechanical Effects of Manual Therapy—A Feasibility Study. DESIGN: Volunteers from identified stakeholder groups were provided with trial material which included the information sheet, consent form, questionnaires and home management booklet. They provided feedback on content (readability, understanding) and style (font, layout). An additional document was provided with genres of pictures to choose the most appropriate style to be used in the booklet. Readability formulas were used to calculate reading age before and after feedback to objectively measure ease of reading. RESULTS: The public group provided a layperson's perspective to clarify the information sheet for patients, whereas practitioner and intern groups indicated where information could be clarified. The reading age of all documentation decreased following feedback; however, templated sections of the documentation did not. The majority (87%) of volunteers chose coloured classic cartoons for the booklet. CONCLUSION: This process highlighted the importance of involving different stakeholder groups in the development of research materials as each group made a unique contribution. Readability and understanding of the trial material were improved, feeding back into the consent process contributing towards fully informed consent. PATIENT OR PUBLIC CONTRIBUTION: Public helped develop materials for a future trial but not with manuscript preparation. John Wiley and Sons Inc. 2020-12-14 2021-04 /pmc/articles/PMC8077147/ /pubmed/33316128 http://dx.doi.org/10.1111/hex.13181 Text en © 2020 The Authors. Health Expectations published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Papers
Rix, Jacqueline
Branney, Jonathan
Breen, Alexander C.
Sewell, Philip
Docherty, Sharon
Stakeholder involvement in the development of trial material for a clinical trial
title Stakeholder involvement in the development of trial material for a clinical trial
title_full Stakeholder involvement in the development of trial material for a clinical trial
title_fullStr Stakeholder involvement in the development of trial material for a clinical trial
title_full_unstemmed Stakeholder involvement in the development of trial material for a clinical trial
title_short Stakeholder involvement in the development of trial material for a clinical trial
title_sort stakeholder involvement in the development of trial material for a clinical trial
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077147/
https://www.ncbi.nlm.nih.gov/pubmed/33316128
http://dx.doi.org/10.1111/hex.13181
work_keys_str_mv AT rixjacqueline stakeholderinvolvementinthedevelopmentoftrialmaterialforaclinicaltrial
AT branneyjonathan stakeholderinvolvementinthedevelopmentoftrialmaterialforaclinicaltrial
AT breenalexanderc stakeholderinvolvementinthedevelopmentoftrialmaterialforaclinicaltrial
AT sewellphilip stakeholderinvolvementinthedevelopmentoftrialmaterialforaclinicaltrial
AT dochertysharon stakeholderinvolvementinthedevelopmentoftrialmaterialforaclinicaltrial